Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 272Leukemia 194Precursor Cell Lymphoblastic Leukemia-Lymphoma 131Lymphoma 108Congenital Abnormalities 68Myelodysplastic Syndromes 63Leukemia, Myelomonocytic, Acute 60Leukemia, Monocytic, Acute 58Leukemia, Erythroblastic, Acute 56Leukemia, Megakaryoblastic, Acute 54Lymphoma, Non-Hodgkin 51Burkitt Lymphoma 44Lymphoma, Mantle-Cell 42Lymphoma, Large B-Cell, Diffuse 41Lymphoma, Follicular 33Leukemia, Myelomonocytic, Chronic 28Anemia, Refractory, with Excess of Blasts 27Hodgkin Disease 26Recurrence 25Lymphoma, Large-Cell, Immunoblastic 25Leukemia, Lymphocytic, Chronic, B-Cell 25Blast Crisis 24Leukemia, Eosinophilic, Acute 19Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Myeloproliferative Disorders 17Leukemia, Basophilic, Acute 17Lymphoma, B-Cell, Marginal Zone 16Leukemia, Promyelocytic, Acute 16Leukemia, Myeloid, Chronic-Phase 15Leukemia, Myeloid, Accelerated Phase 14

Interventions

Gemcitabine 74Capecitabine 60Paclitaxel 59Fluorouracil 58Oxaliplatin 57Bevacizumab 51Docetaxel 50Leucovorin 48Nivolumab 40Cisplatin 40Irinotecan 39Carboplatin 37Cetuximab 34pembrolizumab 32Radiosurgery 32Trastuzumab 30Radiotherapy 27Everolimus 24Sorafenib 23Pemetrexed 20Doxorubicin 20Albumin-Bound Paclitaxel 20Ipilimumab 19Cyclophosphamide 19Panitumumab 18Zoledronic Acid 17Lapatinib 17Erlotinib Hydrochloride 17Prednisone 16pazopanib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasm Metastasis × Cytarabine × Clear all
NCT02067143 2021-09-08

LAL1913

Gruppo Italiano Malattie EMatologiche dell'Adulto

Phase 2 Completed
204 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasm, Residual

NCT00266136 2012-10-26

Biology and Treatment Strategy of AML in Its Subgroups: Multicenter Randomized Trial by the German Acute Myeloid Leukemia Cooperative Group (AMLCG)

University Hospital Muenster

Phase 3 Completed
3,500 enrolled
Other hematologic neoplasm

Neoplasm Metastasis, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡